$4 Million Public Offering Priced by Sonoma Pharmaceuticals, Including Warrants
SNOA is trading near its 52-week low of $1.795 (28% below the low) on elevated volume (8.1× avg).
Summary
Sonoma Pharmaceuticals has priced its public offering at $4 million, consisting of 2,962,963 shares of common stock and an equal number of warrants, both priced at $1.35 per unit. This follows the company's S-1 and S-1/A filings on April 17th and 23rd, which initially indicated a $5 million offering. Given the company's current market capitalization of approximately $3.1 million and its previously reported "going concern" warning, this $4 million offering is highly dilutive and will likely exert significant downward pressure on the stock, which is already trading near its 52-week low. The proceeds are intended for general corporate purposes and working capital. Investors should monitor the closing of the offering on April 27th and its immediate impact on the company's financial health and share price.
At the time of this announcement, SNOA was trading at $1.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.1M. The 52-week trading range was $1.80 to $6.92. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Access Newswire.